Literature DB >> 35292810

Room to Grow: The Need for Cancer Site-Specific Research Into Biomarkers of Aging and Immunity in People With HIV.

Anna E Coghill1,2, Brittney L Dickey1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35292810      PMCID: PMC9194629          DOI: 10.1093/jnci/djac056

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  12 in total

1.  CD4/CD8 ratio and lung cancer risk.

Authors:  Gary M Clifford; Mauro Lise; Silvia Franceschi; Alexandra U Scherrer
Journal:  Lancet HIV       Date:  2017-03       Impact factor: 12.767

2.  Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.

Authors:  Meredith S Shiels; Jessica Y Islam; Philip S Rosenberg; H Irene Hall; Evin Jacobson; Eric A Engels
Journal:  Ann Intern Med       Date:  2018-05-08       Impact factor: 25.391

3.  Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-07-03       Impact factor: 17.586

4.  Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada.

Authors:  Raúl U Hernández-Ramírez; Li Qin; Haiqun Lin; Wendy Leyden; Romain S Neugebauer; Keri N Althoff; Nancy A Hessol; Chad J Achenbach; John T Brooks; M John Gill; Surbhi Grover; Michael A Horberg; Jun Li; W Christopher Mathews; Angel M Mayor; Pragna Patel; Charles S Rabkin; Anita Rachlis; Amy C Justice; Richard D Moore; Eric A Engels; Michael J Silverberg; Robert Dubrow
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

5.  Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study.

Authors:  Keith Sigel; Juan Wisnivesky; Kristina Crothers; Kirsha Gordon; Sheldon T Brown; David Rimland; Maria C Rodriguez-Barradas; Cynthia Gibert; Matthew Bidwell Goetz; Roger Bedimo; Lesley S Park; Robert Dubrow
Journal:  Lancet HIV       Date:  2016-12-02       Impact factor: 12.767

6.  Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.

Authors:  Marguerite Guiguet; François Boué; Jacques Cadranel; Jean-Marie Lang; Eric Rosenthal; Dominique Costagliola
Journal:  Lancet Oncol       Date:  2009-10-07       Impact factor: 41.316

7.  Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.

Authors:  Raúl U Hernández-Ramírez; Meredith S Shiels; Robert Dubrow; Eric A Engels
Journal:  Lancet HIV       Date:  2017-08-10       Impact factor: 12.767

Review 8.  Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression.

Authors:  Boghuma K Titanji; Marta Gwinn; Vincent C Marconi; Yan V Sun
Journal:  Clin Epigenetics       Date:  2022-01-11       Impact factor: 6.551

9.  Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency Virus.

Authors:  Michael J Silverberg; Wendy Leyden; Raúl U Hernández-Ramírez; Li Qin; Haiqun Lin; Amy C Justice; Nancy A Hessol; Chad J Achenbach; Gypsyamber D'Souza; Eric A Engels; Keri N Althoff; Angel M Mayor; Timothy R Sterling; Mari M Kitahata; Ronald J Bosch; Michael S Saag; Charles S Rabkin; Michael A Horberg; M John Gill; Surbhi Grover; W Christopher Mathews; Jun Li; Heidi M Crane; Stephen J Gange; Bryan Lau; Richard D Moore; Robert Dubrow; Romain S Neugebauer
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 9.079

10.  Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015.

Authors:  Marie-Josèphe Horner; Meredith S Shiels; Ruth M Pfeiffer; Eric A Engels
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.